Lista de obras - Eduardo Angles-cano - Dominio Público Uruguay

A method for the determination of the affinity constant of antibodies to tissue plasminogen activator

artículo científico publicado en 1988

A solid-phase fibrin immunoassay for the specific detection of monoclonal antibodies against different epitopic determinants of tissue-plasminogen activators

scientific article published on 01 April 1984

A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators

artículo científico publicado en 1986

Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis

scientific article published on 01 August 1996

Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome

artículo científico publicado en 2000

Apo(a) phenotyping and long-term prognosis for coronary artery disease

artículo científico publicado en 2010

Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.

artículo científico publicado en 2002

Bivalency of plasminogen monoclonal antibodies is required for plasminogen bridging to fibrin and enhanced plasmin formation

artículo científico publicado en 2002

Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines

artículo científico publicado en 1991

Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasma

scientific article published on 01 March 1996

Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site

scientific article published on 01 September 1999

Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator

scientific article published on 01 January 1994

Endothelial fibrinolytic response onto an evolving matrix of fibrin

artículo científico publicado en 2016

Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.

artículo científico publicado en 2015

Experimental Study of Fibrin/Fibrin-Specific Molecular Interactions Using a Sphere/Plane Adhesion Model

artículo científico publicado en 2001

Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases

artículo científico publicado en 2003

Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis

artículo científico publicado en 2005

Heterogeneity of plasminogen activator expression in various Moloney virus-induced tumor cell lines. Lack of correlation with tumor growth and cell phenotype

artículo científico publicado en 1984

Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.

artículo científico publicado en 2003

Immobilisation of monocytes to a solid support: a model for the study of ligand-binding interactions and plasminogen activation at the cell surface.

artículo científico publicado en 1999

Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site

artículo científico publicado en 2001

Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis

artículo científico publicado en 2012

Lipoprotein Lp(a) and atherothrombotic disease.

artículo científico publicado en 2000

Lipoprotein(a) and homocysteine potentiate the risk of coronary artery disease in male subjects

scientific article published on 18 May 2012

Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.

artículo científico publicado en 2002

Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.

artículo científico publicado en 2011

Membrane microvesicles: a circulating source for fibrinolysis, new antithrombotic messengers.

artículo científico publicado en 2013

Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface

artículo científico publicado en 1993

Molecular requirements for safer generation of thrombolytics by bioengineering the tissue-type plasminogen activator A chain.

artículo científico publicado en 2013

Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis

scientific article published on 01 October 1995

Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a)

artículo científico publicado en 2004

Pericellular plasmin induces smooth muscle cell anoikis.

artículo científico publicado en 2003

Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertension

artículo científico publicado en 2002

Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin

artículo científico publicado en 1992

Plasminogen in cerebrospinal fluid originates from circulating blood

artículo científico publicado en 2014

Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model

artículo científico publicado en 2016

Release of VIII R:Ag and VIII R:WF during thrombin and collagen induced aggregation ⬇️

artículo científico publicado el 1 de enero de 1979

Serum antibodies to distinct epitopes of the tissue-type plasminogen activator (t-PA) in patients with systemic lupus erythematosus

scientific article published on 01 June 1995

Solid-phase fibrin-tissue-plasminogen-activator activity assay (SOFIA-tPA): tPA but not UK is specifically detected

artículo científico publicado en 1986

Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen

artículo científico publicado en 1994

Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo

artículo científico publicado en 2012

The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin

scientific article published on 01 May 1996

The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1

artículo científico publicado en 1991

The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat

artículo científico publicado en 2004

Lista de obras de Eduardo Angles-cano

A method for the determination of the affinity constant of antibodies to tissue plasminogen activator

A solid-phase fibrin immunoassay for the specific detection of monoclonal antibodies against different epitopic determinants of tissue-plasminogen activators

A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators

Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis

Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome

Apo(a) phenotyping and long-term prognosis for coronary artery disease

Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.

Bivalency of plasminogen monoclonal antibodies is required for plasminogen bridging to fibrin and enhanced plasmin formation

Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines

Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasma

Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site

Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator

Endothelial fibrinolytic response onto an evolving matrix of fibrin

Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.

Experimental Study of Fibrin/Fibrin-Specific Molecular Interactions Using a Sphere/Plane Adhesion Model

Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases

Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis

Heterogeneity of plasminogen activator expression in various Moloney virus-induced tumor cell lines. Lack of correlation with tumor growth and cell phenotype

Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.

Immobilisation of monocytes to a solid support: a model for the study of ligand-binding interactions and plasminogen activation at the cell surface.

Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site

Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis

Lipoprotein Lp(a) and atherothrombotic disease.

Lipoprotein(a) and homocysteine potentiate the risk of coronary artery disease in male subjects

Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.

Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.

Membrane microvesicles: a circulating source for fibrinolysis, new antithrombotic messengers.

Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface

Molecular requirements for safer generation of thrombolytics by bioengineering the tissue-type plasminogen activator A chain.

Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis

Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a)

Pericellular plasmin induces smooth muscle cell anoikis.

Plasminogen activation by blood monocytes and alveolar macrophages in primary pulmonary hypertension

Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin

Plasminogen in cerebrospinal fluid originates from circulating blood

Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model

Release of VIII R:Ag and VIII R:WF during thrombin and collagen induced aggregation ⬇️

Serum antibodies to distinct epitopes of the tissue-type plasminogen activator (t-PA) in patients with systemic lupus erythematosus

Solid-phase fibrin-tissue-plasminogen-activator activity assay (SOFIA-tPA): tPA but not UK is specifically detected

Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen

Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo

The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin

The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1

The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat